Clinical Trials Browser

Not yet recruiting × toripalimab × Dermatologic × Clear all

NCT05539118 2022-09-14

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

Phase 1/2 Not yet recruiting

Melanoma